Similar articles

• Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection : an observational multicenter study.

  Saliba F, Lakehal M, Pageaux GP, Roche B, Vanlemmens C, Duvoux C, Dumortier J, Salamé E, Calmus Y, Maugendre D; Diapason Study Group. Saliba F, et al. Liver Transpl. 2007 Jan;13(1):136-44. doi: 10.1002/lt.21010. Liver Transpl. 2007. PMID: 17192854
• Predictors of graft and patient survival in subjects undergoing transplantation for hepatitis C virus infection.

  Audimoolam VK, Foxton MR, Agarwal K, O'Grady JG, Heneghan MA. Audimoolam VK, et al. Liver Transpl. 2010 Apr;16(4):536-7. doi: 10.1002/lt.22015. Liver Transpl. 2010. PMID: 20373465 No abstract available.
• Treating chronic hepatitis C virus after liver transplantation: balancing the risks against the chance for success.

  Shiffman ML. Shiffman ML. Liver Transpl. 2007 Aug;13(8):1088-91. doi: 10.1002/lt.21190. Liver Transpl. 2007. PMID: 17663409 No abstract available.
• Extrahepatic hepatitis C virus after transplantation: diabetes and renal dysfunction.

  Sabharwal S, Delgado-Borrego A, Chung RT. Sabharwal S, et al. Liver Transpl. 2008 Oct;14 Suppl 2:S51-7. doi: 10.1002/lt.21613. Liver Transpl. 2008. PMID: 18825714 Review.
• Management of liver transplant recipients with recurrent hepatitis C.

  McCashland TM. McCashland TM. Curr Opin Organ Transplant. 2009 Jun;14(3):221-4. doi: 10.1097/MOT.0b013e32832ade76. Curr Opin Organ Transplant. 2009. PMID: 19444107 Review.